Purinergic Signaling in the Hallmarks of Cancer
Cancer is a complex expression of an altered state of cellular differentiation associated with severe clinical repercussions. The effort to characterize this pathological entity to understand its underlying mechanisms and visualize potential therapeutic strategies has been constant. In this context,...
Main Authors: | Anaí del Rocío Campos-Contreras, Mauricio Díaz-Muñoz, Francisco G. Vázquez-Cuevas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1612 |
Similar Items
-
Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
by: Rosa Gomez-Villafuertes, et al.
Published: (2020-07-01) -
Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”
by: Francisco Ciruela, et al.
Published: (2021-09-01) -
Extracellular ATP: A Feasible Target for Cancer Therapy
by: Valentina Vultaggio-Poma, et al.
Published: (2020-11-01) -
Purinergic Regulation of Neutrophil Function
by: Xu Wang, et al.
Published: (2018-03-01) -
Editorial: Purinergic Pharmacology
by: Francisco Ciruela, et al.
Published: (2019-01-01)